Testing effectiveness (Phase 2)WithdrawnNCT04546828
What this trial is testing
A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea
Who this might be right for
Intrahepatic Cholangiocarcinoma
Samsung Medical Center